心血管疾病死亡率曲线:贝塞斯达+40年及以后
David Calvin Goff1, Sadiya Sana Khan2, Donald Lloyd-Jones2
1Division of Cardiovascular Sciences (D.C.G., G.S.W.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Circulation
|February 22, 2021
概括
冠心病死亡率的下降可能正在逆转,心力衰竭死亡率正在上升. 一场研讨会回顾了自1978年以来的进展,并讨论了改善心血管健康的策略.
科学领域:
- 心血管疾病流行病学
- 公共卫生政策
- 预防性心脏病学
背景情况:
- 1978年贝塞斯达会议为了解冠心病死亡率的下降提供了框架.
- 最近的趋势表明,心脏病死亡率下降已经停滞或逆转,心力衰竭 (HF) 死亡率增加.
- 在知识和治疗方面的进步并没有完全阻止心血管疾病 (CVD) 的不良趋势.
研究的目的:
- 为了纪念1978年贝塞斯达会议40周年.
- 评估1978年会议的成果,并评估目前的CVD环境.
- 确定保护和促进心血管健康和预防心血管疾病的机会.
主要方法:
- 召开了"扭曲心血管疾病死亡率:贝塞斯达+40"研讨会.
- 讨论了心血管疾病,肥胖和糖尿病的趋势和预测.
- 探讨了促进心血管健康的挑战和障碍.
主要成果:
- 整体心血管疾病死亡率正在减缓,但高风死亡率正在上升.
- 随着肥胖和糖尿病的流行,
- 提出了一个早期干预和观察研究的框架.
结论:
- 心血管疾病死亡率的轨迹复杂, 需要重新关注.
- 针对婴儿早期的干预措施,包括在子宫内进行的干预,对于长期的心血管健康至关重要.
- 解决肥胖和糖尿病问题对于预防未来的心血管疾病至关重要.
相关概念视频
Bias in Epidemiological Studies
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...


